Full Text
PCN108 SOCIETAL COST SAVINGS ASSOCIATED WITH BEVACIZUMAB-BASED TREATMENT IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN ITALY

Abstract

Authors

E Mueller M Nuijten S Ravera S Stanisic S Walzer

Back to Volume 13, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×